MedStar Health Launches Participation in Phase 3 MAGNITUDE Gene-Editing Study with First U.S. Heart Patient Treated at MedStar Washington Hospital Center

The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center. 

Read More

Designed by doctors. Powered by AI. 
Owned by you.

© 2024 All rights reserved

Linkedin Facebook